Charles McWherter, President of R&D at CymaBay Therapeutics, Inc. (CBAY), sold 22,664 shares at $21.49 ($487K) on 2023-12-18, disclosed to the SEC on 2023-12-18.
Open-market sale of $487k CBAY by President of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.48 | 6,504 | $140K | 28.7% |
| 2 | $21.48 | 6,504 | $140K | 28.7% |
| 3 | $21.49 | 4,828 | $104K | 21.3% |
| 4 | $21.49 | 4,828 | $104K | 21.3% |
| Total | $21.48 avg | 22,664 | $487K | 100% |
| Filing → |
| CBAY | SELL | 2024-01-22 | $752K | — | Filing → |
| CBAY | SELL | 2023-11-17 | $415K | — | Filing → |
| CBAY | SELL | 2023-10-18 | $612K | — | Filing → |